Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid Tumors.

Abramson VG, Supko JG, Ballinger T, Cleary JM, Hilton JF, Tolaney SM, Chau NG, Cho DC, Pearlberg J, Lager J, Shapiro GI, Arteaga CL.

Clin Cancer Res. 2017 Jul 15;23(14):3520-3528. doi: 10.1158/1078-0432.CCR-16-1764. Epub 2016 Dec 28.

2.

Representing and decomposing genomic structural variants as balanced integer flows on sequence graphs.

Zerbino DR, Ballinger T, Paten B, Hickey G, Haussler D.

BMC Bioinformatics. 2016 Sep 29;17(1):400.

3.

Abnormalities in white matter connections between orbitofrontal cortex and anterior cingulate cortex and their associations with negative symptoms in schizophrenia: a DTI study.

Ohtani T, Bouix S, Hosokawa T, Saito Y, Eckbo R, Ballinger T, Rausch A, Melonakos E, Kubicki M.

Schizophr Res. 2014 Aug;157(1-3):190-7. doi: 10.1016/j.schres.2014.05.016. Epub 2014 Jun 21.

4.

Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.

Abramson VG, Cooper Lloyd M, Ballinger T, Sanders ME, Du L, Lai D, Su Z, Mayer I, Levy M, LaFrance DR, Vnencak-Jones CL, Shyr Y, Dahlman KB, Pao W, Arteaga CL.

Breast Cancer Res Treat. 2014 Jun;145(2):389-99. doi: 10.1007/s10549-014-2945-3. Epub 2014 Apr 11.

5.

CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging study.

Clemm von Hohenberg C, Wigand MC, Kubicki M, Leicht G, Giegling I, Karch S, Hartmann AM, Konte B, Friedl M, Ballinger T, Eckbo R, Bouix S, J├Ąger L, Shenton ME, Rujescu D, Mulert C.

J Psychiatr Res. 2013 Oct;47(10):1349-56. doi: 10.1016/j.jpsychires.2013.07.002. Epub 2013 Jul 17.

6.

Decreased axial diffusivity within language connections: a possible biomarker of schizophrenia risk.

Kubicki M, Shenton ME, Maciejewski PK, Pelavin PE, Hawley KJ, Ballinger T, Swisher T, Jabbar GA, Thermenos HW, Keshavan MS, Seidman LJ, Delisi LE.

Schizophr Res. 2013 Aug;148(1-3):67-73. doi: 10.1016/j.schres.2013.06.014. Epub 2013 Jun 22.

7.

White matter microstructure in individuals at clinical high risk of psychosis: a whole-brain diffusion tensor imaging study.

von Hohenberg CC, Pasternak O, Kubicki M, Ballinger T, Vu MA, Swisher T, Green K, Giwerc M, Dahlben B, Goldstein JM, Woo TU, Petryshen TL, Mesholam-Gately RI, Woodberry KA, Thermenos HW, Mulert C, McCarley RW, Seidman LJ, Shenton ME.

Schizophr Bull. 2014 Jul;40(4):895-903. doi: 10.1093/schbul/sbt079. Epub 2013 Jun 4.

8.

Reduced fractional anisotropy and axial diffusivity in white matter in 22q11.2 deletion syndrome: a pilot study.

Kikinis Z, Asami T, Bouix S, Finn CT, Ballinger T, Tworog-Dube E, Kucherlapati R, Kikinis R, Shenton ME, Kubicki M.

Schizophr Res. 2012 Oct;141(1):35-9. doi: 10.1016/j.schres.2012.06.032. Epub 2012 Aug 3.

9.

Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications.

Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, Olshen A, Ballinger T, Zhou X, Forsberg KJ, Gu J, Echipare L, O'Geen H, Lister R, Pelizzola M, Xi Y, Epstein CB, Bernstein BE, Hawkins RD, Ren B, Chung WY, Gu H, Bock C, Gnirke A, Zhang MQ, Haussler D, Ecker JR, Li W, Farnham PJ, Waterland RA, Meissner A, Marra MA, Hirst M, Milosavljevic A, Costello JF.

Nat Biotechnol. 2010 Oct;28(10):1097-105. doi: 10.1038/nbt.1682. Epub 2010 Sep 19.

Supplemental Content

Loading ...
Support Center